Sodium Bicarbonate Injection, Solution
Product Images NDC 0409-6637

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sodium Bicarbonate (NDC 0409-6637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Sodium 01)

FDA Label Image

Hospira Logo (Sodium 02)

FDA Label Image

Principal Display Panel (0.9 mEq/mL Syringe Label)

Principal Display Panel (0.9 mEq/mL Syringe Label)
Label for Sodium Bicarbonate 7.5% Injection, USP, 50 mL single-dose vial from Hospira, Inc. It shows concentration as 44.6 mEq/50 mL (0.9 mEq/mL) with a pH range of 7.0 to 8.5. The label includes volume markings up to 50 mL and states the product is sterile and nonpyrogenic for intravenous use.*
FDA Label Image

Principal Display Panel (0.9 mEq/mL Syringe Carton)

Principal Display Panel (0.9 mEq/mL Syringe Carton)
The packaging label for Sodium Bicarbonate Injection, USP, 7.5% strength at 44.6 mEq/50 mL (0.9 mEq/mL) in a 50 mL glass unit of use syringe. The label includes the brand LIFESHIELD and ABBJECT glass syringe with male luer lock adapter and 18-gauge protected needle. It is for intravenous use and marked Rx only. The labeler is Hospira, Inc., Lake Forest, IL, USA, with NDC 0409-4916-24. The label features instructions for aseptic technique and syringe assembly.*
FDA Label Image

Principal Display Panel (1 mEq/mL Syringe Label)

Principal Display Panel (1 mEq/mL Syringe Label)
Label for 8.4% Sodium Bicarbonate Injection, USP at 1 mEq/mL strength, with a 50 mL single-dose vial. The label shows volume scale markings, the NDC 0409-6637-24, and states it is for intravenous use, sterile and nonpyrogenic. Manufactured by Hospira, Inc., Lake Forest, IL.*
FDA Label Image

Principal Display Panel (1 mEq/mL Syringe Carton)

Principal Display Panel (1 mEq/mL Syringe Carton)
Sodium Bicarbonate Injection, USP 8.4% (84 mg/mL) in a 50 mL glass unit dose syringe by Hospira, Inc. The label includes usage instructions for IV administration with a male luer lock adapter and 18-gauge protected needle. The packaging cautions about handling the liquid-filled glass syringe carefully and provides aseptic technique guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.